French pharmaceutical company Servier has swooped on Agios Pharma’s marketed and experimental cancer drugs, buying the entire franchise in a deal that leaves the US biopharma focused on genetic ...

Servier looks like it could bring a second IDH inhibitor from its 2021 takeover of Agios’ oncology business to market, after reporting positive results in a phase 3 brain cancer trial. The drug ...

Understand the cash flow statement for Agios Pharmaceuticals, Inc. (AGIO), learn where the money comes from and how the company spends it.

Get the detailed quarterly/annual income statement for Agios Pharmaceuticals, Inc. (AGIO). Find out the revenue, expenses and profit or loss over the last fiscal year.

Get the latest news and real-time alerts from Agios Pharmaceuticals, Inc. (AGIO) stock at Seeking Alpha.

Find the latest Agios Pharmaceuticals, Inc. (AGIO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Agios Pharmaceuticals, Inc. (AGIO) earnings report: revenue, EPS, surprise, history, news and analysis.